Page last updated: 2024-11-08

olivose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

olivose: RN given for (D)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10888063
CHEBI ID139377
SCHEMBL ID9542066
MeSH IDM0362505

Synonyms (18)

Synonym
olivose
OLI ,
CHEBI:139377
SCHEMBL9542066
2,6-dideoxy-arabinopyranose
2,6-dideoxy-arabino-hexopyranose
2,6-dideoxy-d-arabinose
2,6-dideoxy-d-arabino-hexopyranose
d-olivose ,
2,6-dideoxy-arabinose
2,6-dideoxy-arabinopyranoside
2,6-dideoxy-d-arabinopyranoside
d-oli
2,6-dideoxy-d-arabinopyranose
C21054
d-canarose
2-deoxy-d-rhamnose
dtxcid70142648
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
hexoseAny six-carbon monosaccharide which in its linear form contains either an aldehyde group at position 1 (aldohexose) or a ketone group at position 2 (ketohexose).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's10 (62.50)29.6817
2010's6 (37.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.25%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (93.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]